ciprofloxacin has been researched along with griseofulvin in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.33) | 18.2507 |
| 2000's | 5 (11.63) | 29.6817 |
| 2010's | 36 (83.72) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cortijo, J; Gálvez, J; García-Domenech, R; Morcillo, E; Ríos-Santamarina, I; Santamaria, P | 1 |
| Bedi, PM; Kapoor, VK; Mahajan, MP | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Dahiya, R; Pathak, D | 1 |
| Holla, BS; Karthikeyan, MS; Kumari, NS; Mahalinga, M; Prasad, DJ | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Dharbhamulla, S; Maddi, VS; Noolvi, MN; Ronad, PM; Sapkal, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Gadakh, AV; Karale, BK; Pandit, C; Rindhe, SS | 1 |
| Haveliwala, DD; Kamdar, NR; Mistry, PT; Patel, SK | 1 |
| Mali, MD; Patel, MM; Patel, SK | 1 |
| Ahmad, A; Farshori, NN; Khan, AU; Rauf, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ahmad, A; Khan, AU; Musthafa, TN; Siddiqui, ZN | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Makawana, JA; Mungra, DC; Patel, MP; Patel, RG | 1 |
| Akhaja, TN; Raval, JP | 1 |
| de Koning, CB; Johnson, MM; Omolo, JJ; van Vuuren, SF | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Patel, MP; Patel, RG; Shah, NM | 1 |
| Bonifácio, VD; Gawande, MB; Mhaske, GR; Shelke, SN | 1 |
| Ishar, MP; Kaur, H; Saxena, AK; Sharma, V; Singh, G | 1 |
| Desai, NC; Joshi, VV; Rajpara, KM | 1 |
| Parmar, BD; Parmar, NJ; Patel, RA; Talpada, NP | 1 |
| Kathrotiya, HG; Patel, MP | 1 |
| Kanawade, SB; Rajani, DP; Toche, RB | 1 |
| Jardosh, HH; Patel, MP | 1 |
| Kalaria, PN; Raval, DK; Satasia, SP | 1 |
| Desai, NC; Kotadiya, GM; Trivedi, AR | 1 |
| Karad, SC; Purohit, VB; Raval, DK | 1 |
| Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Kamani, RD; Karad, SC; Purohit, VB; Raval, DK; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P; Thummar, RP; Vaghasiya, BK | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
| Pathak, P; Pratap Singh, K; Sagar, R; Tiwari, S | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P | 1 |
| Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Jena, SS; Karuppasamy, M; Lakshmanan, B; Mazumder, PM; Pattnaik, AK; Selvaraj, N | 1 |
3 review(s) available for ciprofloxacin and griseofulvin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
40 other study(ies) available for ciprofloxacin and griseofulvin
| Article | Year |
|---|---|
New bronchodilators selected by molecular topology.
Topics: Animals; Bronchodilator Agents; Discriminant Analysis; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Structure-Activity Relationship; Trachea | 1998 |
Amidine derived 1,3-diazabuta-1,3-dienes as potential antibacterial and antifungal agents.
Topics: Alkylation; Amidines; Anti-Bacterial Agents; Antifungal Agents; Butadienes; Candida albicans; Gram-Negative Bacteria; Gram-Positive Bacteria; Isothiocyanates; Molecular Structure; Piperidines | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthetic studies on novel benzimidazolopeptides with antimicrobial, cytotoxic and anthelmintic potential.
Topics: Animals; Anthelmintics; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Cytotoxins; Fungi; Humans; Oligochaeta; Peptides; Protein Conformation | 2007 |
Antimicrobial studies of 2,4-dichloro-5-fluorophenyl containing oxadiazoles.
Topics: Anti-Infective Agents; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Oxadiazoles; Spectrophotometry, Infrared; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives.
Topics: Anti-Infective Agents; Bacteria; Coumarins; Fungi; Spectrum Analysis; Thiazolidines | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacillus subtilis; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Escherichia coli; Fluorine; Humans; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Design, synthesis and in vitro evaluation of antitubercular and antimicrobial activity of some novel pyranopyrimidines.
Topics: Anti-Infective Agents; Aspergillus niger; Bacteria; Drug Design; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyrimidines | 2010 |
Bernthsen synthesis, antimicrobial activities and cytotoxicity of acridine derivatives.
Topics: Acridines; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus niger; Bacteria; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2010 |
A facile, one-pot synthesis, characterization and antimicrobial activity of o-hydroxy anilide derivatives and 1-substituted-1,3-dicyclohexylurea analogs of long chain carboxylic acids.
Topics: Anilides; Anti-Infective Agents; Bacteria; Carboxylic Acids; Fungi; Microbial Sensitivity Tests; Urea | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Thermal solvent-free synthesis of novel pyrazolyl chalcones and pyrazolines as potential antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Chalcones; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Solvents; Temperature | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microwaves; Mycoses; Pyrans; Quinolines | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzofurans; Benzoquinones; Candida albicans; Cryptococcus neoformans; Molecular Structure; Spiro Compounds; Xanthones | 2011 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Green Chemistry Technology; Halogenation; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Pyrazoles; Tuberculosis | 2012 |
Synthesis of β-ionone derived chalcones as potent antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chalcones; Fungi; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycoses; Norisoprenoids; Staphylococcal Infections | 2012 |
Synthesis and characterization of some new quinoline based derivatives endowed with broad spectrum antimicrobial potency.
Topics: Anti-Infective Agents; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Conformation; Quinolines; Structure-Activity Relationship; Thiazoles | 2012 |
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
Topics: Aldehydes; Anti-Bacterial Agents; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Ionic Liquids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrans; Pyrazolones; Quinolines; Structure-Activity Relationship | 2013 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzoxazines; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Studies on molecular properties prediction, antitubercular and antimicrobial activities of novel quinoline based pyrimidine motifs.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Quinolines; Structure-Activity Relationship | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis and biological screening of novel 2-morpholinoquinoline nucleus clubbed with 1,2,4-oxadiazole motifs.
Topics: Anti-Infective Agents; Bacteria; Bacterial Proteins; Catalytic Domain; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Fungi; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2017 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
One-pot two-step facile synthesis of 2,3,4,5-tetra substituted dihydrooxazoles and their antimicrobial activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Oxazoles; Structure-Activity Relationship | 2017 |
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2017 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Evaluation of wound healing and antimicrobial potentials of Ixora coccinea root extract.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Chloramphenicol; Ciprofloxacin; Disease Models, Animal; Griseofulvin; Mycoses; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Rubiaceae; Tensile Strength; Wound Healing | 2011 |